Online Program Home
My Program

CC = Vancouver Convention Centre   F = Fairmont Waterfront Vancouver
* = applied session       ! = JSM meeting theme

Activity Details

525 ! Wed, 8/1/2018, 10:30 AM - 12:20 PM CC-West 209
Clinical Trial Design- 6 — Contributed Papers
Biopharmaceutical Section
Chair(s): Rachael Wen, Sanofi
10:35 AM Asymptotic MinP Method for Responder Analysis
Ming Zhou, Bristol-Myers Squibb Company; Mark Donovan, Bristol-Myers Squibb
10:50 AM Estimating Probability of Simultaneous Success with Multiple Endpoints Using Truncated Multi-Variate Correlated Normal Distribution

Tianshuang Wu, AbbVie; Yihua Gu, AbbVie; Ziqian Geng, AbbVie; Saurabh Mukhopadhyay, AbbVie
11:05 AM Measuring the Individual Benefits of a Medical or Behavioral Treatment Using Generalized Linear Mixed-Effects Models
Francisco Diaz, The University of Kansas Medical Center
11:20 AM Comparison of Support Vector Machine and Conformal Inference of in Regression Prediction

Kao-Tai Tsai, Celgene
11:35 AM Adaptive Dose Finding in Oncology Phase I-II Studies with Consideration of Tolerability and Efficacy
Rachael Liu, Takeda Pharmaceuticals ; Ling Wang, Takeda; David Sinclair, Google; Jianchang Lin, Takeda Pharmaceuticals
11:50 AM How the ICH E9 Addendum Influenced a Phase III Clinical Trial with a Radiographic Endpoint
Ruvie Martin, Novartis Pharmaceuticals
12:05 PM Floor Discussion